• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病肾病和非糖尿病肾病患者的血压及血磷水平:横断面“低清除率会诊”研究结果

Blood pressure and phosphate level in diabetic and non-diabetic kidney disease: Results of the cross-sectional "Low Clearance Consultation" study.

作者信息

Mendes Margarida, Resende Luis, Teixeira Alves, Correia João, Silva Gil

机构信息

SESARAM, Bom Jesus Health Centre, Madeira, Portugal.

SESARAM, Nephrology Department, Madeira, Portugal.

出版信息

Porto Biomed J. 2017 Nov-Dec;2(6):301-305. doi: 10.1016/j.pbj.2017.02.005. Epub 2017 Mar 30.

DOI:10.1016/j.pbj.2017.02.005
PMID:32258786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6806749/
Abstract

HIGHLIGHTS

A statistically significant and moderate positive correlation was verified between systolic blood pressure and plasma phosphate concentration in the whole sample (diabetic and non-diabetic), due to the diabetic chronic kidney disease group.A statistically significant and moderate positive correlation was verified between the diastolic blood pressure and plasma phosphate concentration in the whole sample (diabetic and non-diabetic), due to the diabetic chronic kidney disease group.A statistically significant and strong negative correlation was found between diastolic blood pressure and estimated glomerular filtration rate in the diabetic chronic kidney disease group, but there was no statistically significant correlation in the whole sample (diabetic and non-diabetic).

ABSTRACT

Diabetic kidney disease features certain clinical and laboratorial characteristics that differ from chronic kidney disease of other etiologies. We performed a transversal study comparing some of these characteristics and assessed potential associations among blood pressure, plasma phosphate concentration and estimated glomerular filtration rate between patients with diabetic and non-diabetic chronic kidney disease.We found a positive correlation between both systolic and diastolic blood pressure and the plasma phosphate concentration in the diabetic kidney disease group, but not in the non-diabetic group. Also, diastolic blood pressure was negatively correlated with the estimated glomerular filtration rate in the diabetic group, yet not in the non-diabetic group.In conclusion, these data support the hypothesis of a close link between systolic and diastolic blood pressure and hyperphosphatemia, as well as between diastolic blood pressure and estimated glomerular filtration rate, in patients with diabetic kidney disease. Therapeutic approaches directed at these factors might prove to be important to delay the decline of renal function in the subgroup of patients with diabetic kidney disease.

摘要

要点

在整个样本(糖尿病患者和非糖尿病患者)中,由于糖尿病慢性肾病组的存在,收缩压与血浆磷酸盐浓度之间证实存在统计学显著且中等程度的正相关。在整个样本(糖尿病患者和非糖尿病患者)中,由于糖尿病慢性肾病组的存在,舒张压与血浆磷酸盐浓度之间证实存在统计学显著且中等程度的正相关。在糖尿病慢性肾病组中,舒张压与估计肾小球滤过率之间发现存在统计学显著且强的负相关,但在整个样本(糖尿病患者和非糖尿病患者)中无统计学显著相关性。

摘要

糖尿病肾病具有某些不同于其他病因慢性肾病的临床和实验室特征。我们进行了一项横断面研究,比较其中一些特征,并评估糖尿病和非糖尿病慢性肾病患者之间血压、血浆磷酸盐浓度和估计肾小球滤过率之间的潜在关联。我们发现糖尿病肾病组的收缩压和舒张压与血浆磷酸盐浓度均呈正相关,但非糖尿病组未出现这种情况。此外,糖尿病组的舒张压与估计肾小球滤过率呈负相关,而非糖尿病组未出现这种情况。总之,这些数据支持以下假设:糖尿病肾病患者的收缩压和舒张压与高磷血症之间以及舒张压与估计肾小球滤过率之间存在密切联系。针对这些因素的治疗方法可能对延缓糖尿病肾病患者亚组的肾功能下降具有重要意义。

相似文献

1
Blood pressure and phosphate level in diabetic and non-diabetic kidney disease: Results of the cross-sectional "Low Clearance Consultation" study.糖尿病肾病和非糖尿病肾病患者的血压及血磷水平:横断面“低清除率会诊”研究结果
Porto Biomed J. 2017 Nov-Dec;2(6):301-305. doi: 10.1016/j.pbj.2017.02.005. Epub 2017 Mar 30.
2
Hypertension and progression of nephropathy in diabetic and non-diabetic chronic kidney disease patients.糖尿病和非糖尿病慢性肾病患者的高血压与肾病进展
Hippokratia. 2007 Apr;11(2):72-6.
3
Nighttime Systolic Blood-Pressure Load Is Correlated with Target-Organ Damage Independent of Ambulatory Blood-Pressure Level in Patients with Non-Diabetic Chronic Kidney Disease.在非糖尿病慢性肾脏病患者中,夜间收缩压负荷与靶器官损害相关,且独立于动态血压水平。
PLoS One. 2015 Jul 17;10(7):e0131546. doi: 10.1371/journal.pone.0131546. eCollection 2015.
4
Monitoring glomerular function in diabetic nephropathy. A prospective study.糖尿病肾病中肾小球功能的监测。一项前瞻性研究。
Am J Med. 1983 Feb;74(2):256-64. doi: 10.1016/0002-9343(83)90624-1.
5
Systolic blood pressure relates to the rate of decline of glomerular filtration rate in type II diabetes.收缩压与II型糖尿病患者肾小球滤过率的下降速率相关。
Diabetes Care. 1993 Nov;16(11):1427-32. doi: 10.2337/diacare.16.11.1427.
6
The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy.代谢控制对伴有显性糖尿病肾病的胰岛素依赖型糖尿病患者肾功能下降速率的影响。
Nephrol Dial Transplant. 1998 Mar;13(3):651-5. doi: 10.1093/ndt/13.3.651.
7
[Results of kidney function measurement and blood pressure in population from endemic region of Vitina].[维蒂纳流行地区人群的肾功能测量及血压结果]
Med Pregl. 2008 Jul-Aug;61(7-8):400-3. doi: 10.2298/mpns0808400s.
8
A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.一项关于伊拉地平与螺普利作为单一疗法及联合疗法对慢性肾衰竭合并高血压患者肾功能下降影响的随机双盲对照研究。
Clin Nephrol. 2001 May;55(5):375-83.
9
BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.糖尿病肾病中的血压与肾脏结局:退伍军人事务部糖尿病肾病试验
Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2159-69. doi: 10.2215/CJN.02850315. Epub 2015 Oct 19.
10
Ambulatory Blood Pressure Trajectories and Blood Pressure Variability in Diabetic and Non-Diabetic Chronic Kidney Disease.糖尿病和非糖尿病慢性肾脏病患者的动态血压轨迹和血压变异性。
Am J Nephrol. 2020;51(5):411-420. doi: 10.1159/000507416. Epub 2020 Apr 7.

引用本文的文献

1
Hyperphosphatemia and its relationship with blood pressure, vasoconstriction, and endothelial cell dysfunction in hypertensive hemodialysis patients.高血压血液透析患者的高磷血症及其与血压、血管收缩和内皮细胞功能障碍的关系。
BMC Nephrol. 2022 Aug 23;23(1):291. doi: 10.1186/s12882-022-02918-0.
2
Phosphate Is a Cardiovascular Toxin.磷是一种心血管毒素。
Adv Exp Med Biol. 2022;1362:107-134. doi: 10.1007/978-3-030-91623-7_11.
3
RAGE Differentially Altered Responses in Vascular Smooth Muscle Cells and Adventitial Fibroblasts in Diabetes-Induced Vascular Calcification.晚期糖基化终末产物受体在糖尿病诱导的血管钙化中对血管平滑肌细胞和外膜成纤维细胞的反应有不同改变。
Front Physiol. 2021 Jun 7;12:676727. doi: 10.3389/fphys.2021.676727. eCollection 2021.
4
Hyperphosphatemia and Cardiovascular Disease.高磷血症与心血管疾病
Front Cell Dev Biol. 2021 Mar 4;9:644363. doi: 10.3389/fcell.2021.644363. eCollection 2021.
5
FGF23 and Phosphate-Cardiovascular Toxins in CKD.成纤维细胞生长因子 23 与慢性肾脏病中的磷-心血管毒素
Toxins (Basel). 2019 Nov 6;11(11):647. doi: 10.3390/toxins11110647.
6
Phosphate, the forgotten mineral in hypertension.磷酸盐,高血压中的被遗忘矿物质。
Curr Opin Nephrol Hypertens. 2019 Jul;28(4):345-351. doi: 10.1097/MNH.0000000000000503.

本文引用的文献

1
Arterial Stiffness and Chronic Kidney Disease.动脉僵硬度与慢性肾脏病
Pulse (Basel). 2016 Apr;3(3-4):229-41. doi: 10.1159/000443616. Epub 2016 Mar 1.
2
Stop chronic kidney disease progression: Time is approaching.阻止慢性肾病进展:时机即将到来。
World J Nephrol. 2016 May 6;5(3):258-73. doi: 10.5527/wjn.v5.i3.258.
3
Time-dependent risk factors associated with the decline of estimated GFR in CKD patients.与慢性肾脏病(CKD)患者估算肾小球滤过率(GFR)下降相关的时间依赖性风险因素。
Clin Exp Nephrol. 2016 Feb;20(1):58-70. doi: 10.1007/s10157-015-1132-0. Epub 2015 Jun 23.
4
Comparison of intrarenal renin-angiotensin system activity in diabetic versus non-diabetic patients with overt proteinuria.糖尿病与非糖尿病显性蛋白尿患者肾内肾素-血管紧张素系统活性的比较。
Nephrology (Carlton). 2015 Apr;20(4):279-85. doi: 10.1111/nep.12383.
5
Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia.磷酸盐过载会直接导致尿毒症患者全身炎症、营养不良和血管钙化。
Am J Physiol Renal Physiol. 2014 Jun 15;306(12):F1418-28. doi: 10.1152/ajprenal.00633.2013. Epub 2014 May 7.
6
Identifying parameters to distinguish non-diabetic renal diseases from diabetic nephropathy in patients with type 2 diabetes mellitus: a meta-analysis.鉴别 2 型糖尿病患者中非糖尿病性肾脏疾病与糖尿病肾病的参数:一项荟萃分析。
PLoS One. 2013 May 14;8(5):e64184. doi: 10.1371/journal.pone.0064184. Print 2013.
7
Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease.高血压和慢性肾脏病患者肾内和尿中的血管紧张素原增加。
Pflugers Arch. 2013 Jan;465(1):3-12. doi: 10.1007/s00424-012-1143-6. Epub 2012 Aug 24.
8
Dietary phosphate binding and loading alter kidney angiotensin-converting enzyme mRNA and protein content in 5/6 nephrectomized rats.饮食磷酸盐结合和负荷改变 5/6 肾切除大鼠肾脏血管紧张素转换酶的 mRNA 和蛋白含量。
Am J Nephrol. 2012;35(5):401-8. doi: 10.1159/000337942. Epub 2012 Apr 19.
9
Phosphate binders: Sevelamer in the prevention and treatment of hyperphosphataemia in chronic renal failure.磷结合剂:司维拉姆在慢性肾衰竭高磷血症防治中的应用
Hippokratia. 2011 Jan;15(Suppl 1):22-6.
10
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.慢性肾脏病中磷结合剂的益处与危害:随机对照试验的系统评价
Am J Kidney Dis. 2009 Oct;54(4):619-37. doi: 10.1053/j.ajkd.2009.06.004. Epub 2009 Aug 18.